Global Oncology Academy - Global Oncology Academy

Global Oncology Academy

Global Oncology Academy

Enhance your practice with CME
and tools that focus on the management
and treatment of patients with cancer.

Popular

Choosing the Path Forward: A Real-World Dialogue on Perioperative Immunotherapy
Choosing the Path Forward: A Real-World Dialogue on Perioperative Immunotherapy
MinuteCE®
Choosing the Path Forward: A Real-World Dialogue on Perioperative Immunotherapy
Adam J. Luginbuhl, MD
0.50 program credits
- Adam J. Luginbuhl, MD
0.50 program credits
Partnering Through Treatment: Preparing for Immunotherapy in the Perioperative Setting
Partnering Through Treatment: Preparing for Immunotherapy in the Perioperative Setting
MinuteCE®
Partnering Through Treatment: Preparing for Immunotherapy in the Perioperative Setting
Jennifer Johnson, MD, PhD
0.50 program credits
- Jennifer Johnson, MD, PhD
0.50 program credits
Emerging TNBC Research: Biomarkers, Genomics, and Adaptive Treatment
Emerging TNBC Research: Biomarkers, Genomics, and Adaptive Treatment
Project Oncology®
Emerging TNBC Research: Biomarkers, Genomics, and Adaptive Treatment
Roberto Leon-Ferre, MD
- Roberto Leon-Ferre, MD
Implementing Lifestyle Medicine in Breast Cancer Survivorship Care
Implementing Lifestyle Medicine in Breast Cancer Survivorship Care
Project Oncology®
Implementing Lifestyle Medicine in Breast Cancer Survivorship Care
Amy Comander, MD
- Amy Comander, MD
Breast Cancer Survivorship: Why Lifestyle Medicine Matters
Breast Cancer Survivorship: Why Lifestyle Medicine Matters
Project Oncology®
Breast Cancer Survivorship: Why Lifestyle Medicine Matters
Amy Comander, MD
- Amy Comander, MD
All Hands on Deck: Multidisciplinary Coordination for Smarter Perioperative Care
All Hands on Deck: Multidisciplinary Coordination for Smarter Perioperative Care
MinuteCE®
All Hands on Deck: Multidisciplinary Coordination for Smarter Perioperative Care
Adam J. Luginbuhl, MD; Jennifer Johnson, MD, PhD
0.50 program credits
- Adam J. Luginbuhl, MD
- Jennifer Johnson, MD, PhD
0.50 program credits
DPYD Testing Before Fluoropyrimidine Therapy: Benefits, Risks, and Guidance
DPYD Testing Before Fluoropyrimidine Therapy: Benefits, Risks, and Guidance
Project Oncology®
DPYD Testing Before Fluoropyrimidine Therapy: Benefits, Risks, and Guidance
Daniel Hertz, PhD, PharmD
- Daniel Hertz, PhD, PharmD
Optimizing First-Line Care for PD-L1–Low Metastatic NSCLC
Optimizing First-Line Care for PD-L1–Low Metastatic NSCLC
Project Oncology®
Optimizing First-Line Care for PD-L1–Low Metastatic NSCLC
Charles Turck, PharmD, BCPS, BCCCP; Deepa Rangachari, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Deepa Rangachari, MD

Medical News

Medical News
Amivantamab Plus Lazertinib in EGFR-Mutant Lung Cancer with CNS Metastases
05/28/2026
Read more
Medical News
Molecular Profiling Guides Adjuvant Therapy in Endometrial Cancer
05/25/2026
Read more
Medical News
BCG Plus Mitomycin Fails to Improve DFS in ANZUP 1301
05/22/2026
Read more
Medical News
Early Postoperative Intake Linked To Complications After GI Cancer Surgery
05/19/2026
Read more

CME/CE

MinuteCE®
Talking Through Treatment: Patient–Clinician Dialogue on Perioperative Immunotherapy in Locally Advanced HNSCC
Jennifer Johnson, MD, PhD; Adam J. Luginbuhl, MD
0.50 credits 5 episodes
- Jennifer Johnson, MD, PhD
- Adam J. Luginbuhl, MD
0.50 credits 5 episodes
Turning Evidence Into Action: Applying Perioperative Data to Real-World Practice
Turning Evidence Into Action: Applying Perioperative Data to Real-World Practice
MinuteCE®
Turning Evidence Into Action: Applying Perioperative Data to Real-World Practice
Jennifer Johnson, MD, PhD
0.50 program credits
- Jennifer Johnson, MD, PhD
0.50 program credits
コンテキストにおける意思決定：脳転移に対する全身療法およびCNS療法の順序決定に関する実践的枠組み
コンテキストにおける意思決定：脳転移に対する全身療法およびCNS療法の順序決定に関する実践的枠組み
CME/CE
コンテキストにおける意思決定：脳転移に対する全身療法およびCNS療法の順序決定に関する実践的枠組み
Barbara O'Brien, MD
0.25 credits
- Barbara O'Brien, MD
0.25 credits
Improving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care
Improving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care
CME/CE
Improving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care
Joseph Kim, MD, MPH, MBA, FACHE; Samir Dalia, MD
0.25 credits
- Joseph Kim, MD, MPH, MBA, FACHE
- Samir Dalia, MD
- Christopher Jurief
0.25 credits

Clinical Practice

Before the Scalpel: Identifying Candidates for Perioperative Immunotherapy
Before the Scalpel: Identifying Candidates for Perioperative Immunotherapy
MinuteCE®
Before the Scalpel: Identifying Candidates for Perioperative Immunotherapy
Adam J. Luginbuhl, MD
0.50 program credits
- Adam J. Luginbuhl, MD
0.50 program credits
Matching TNBC Treatment Intensity to Patient Needs
Matching TNBC Treatment Intensity to Patient Needs
Project Oncology®
Matching TNBC Treatment Intensity to Patient Needs
Roberto Leon-Ferre, MD
- Roberto Leon-Ferre, MD
Survival Outcomes in Squamous Cell Carcinoma of the Anal Canal: POD1UM-303 Data
Survival Outcomes in Squamous Cell Carcinoma of the Anal Canal: POD1UM-303 Data
Project Oncology®
Survival Outcomes in Squamous Cell Carcinoma of the Anal Canal: POD1UM-303 Data
Brian P. McDonough, MD, FAAFP; Stacey Cohen, MD
- Brian P. McDonough, MD, FAAFP
- Stacey Cohen, MD
Making the Right Moves in Metastatic CSPC: Intensification, Imaging, and Impact
Making the Right Moves in Metastatic CSPC: Intensification, Imaging, and Impact
CME/CE
Making the Right Moves in Metastatic CSPC: Intensification, Imaging, and Impact
Neeraj Agarwal, MD, FASCO; Rana McKay, MD
0.25 credits
- Neeraj Agarwal, MD, FASCO
- Rana McKay, MD
0.25 credits

Programs

Optimizing cGVHD Treatment Decisions in the Second- and Third-Line Settings
Optimizing cGVHD Treatment Decisions in the Second- and Third-Line Settings
Project Oncology®
Optimizing cGVHD Treatment Decisions in the Second- and Third-Line Settings
Charles Turck, PharmD, BCPS, BCCCP; Stephanie Gregory, CNP
- Charles Turck, PharmD, BCPS, BCCCP
- Stephanie Gregory, CNP
Managing Immune-Related Adverse Events in Metastatic NSCLC
Managing Immune-Related Adverse Events in Metastatic NSCLC
Project Oncology®
Managing Immune-Related Adverse Events in Metastatic NSCLC
Charles Turck, PharmD, BCPS, BCCCP; Paul Bunn, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Paul Bunn, MD
Real-World Strategies for Complex cGVHD Treatment Decisions
Real-World Strategies for Complex cGVHD Treatment Decisions
Project Oncology®
Real-World Strategies for Complex cGVHD Treatment Decisions
Brian P. McDonough, MD, FAAFP; Doris M. Ponce, MD, MS
- Brian P. McDonough, MD, FAAFP
- Doris M. Ponce, MD, MS
Interpreting Perioperative Trial Designs in Resectable NSCLC Research
Interpreting Perioperative Trial Designs in Resectable NSCLC Research
Project Oncology®
Interpreting Perioperative Trial Designs in Resectable NSCLC Research
Charles Turck, PharmD, BCPS, BCCCP; Laura Alder, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Laura Alder, MD
- Christine Bestvina, MD